Literature DB >> 2996003

Presence of an allelic EcoRI restriction fragment of the c-mos locus in leukocyte and tumor cell DNAs of breast cancer patients.

R Lidereau, D Mathieu-Mahul, C Theillet, M Renaud, M Mauchauffé, J Gest, C J Larsen.   

Abstract

Structure of the human c-mos protooncogene in DNAs from breast tumors, leukemic cells, and lymphocytes from normal individuals was analyzed by restriction enzyme digestion and Southern blot. In 6 of 75 breast tumor DNAs, we found an EcoRI 5-kilobase extra band hybridizing with a human c-mos probe containing all of the sequences homologous to v-mos oncogene. This band was also found in lymphocyte DNA from 3 of these patients, indicating a restriction fragment length polymorphism. This polymorphism was not found in a series of 69 lymphocyte DNAs from the unaffected population. Moreover, 1 of 73 leukemic cell DNAs exhibited the 5-kilobase band. These results indicate that this rare polymorphism is significantly more frequently found in patients with breast cancer than in the rest of the population (P less than 0.05, by a chi 2 test with Yates correction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996003      PMCID: PMC391311          DOI: 10.1073/pnas.82.20.7068

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients.

Authors:  T G Krontiris; N A DiMartino; M Colb; D R Parkinson
Journal:  Nature       Date:  1985 Jan 31-Feb 6       Impact factor: 49.962

Review 2.  Cellular oncogenes and retroviruses.

Authors:  J M Bishop
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

3.  Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like element.

Authors:  G Rechavi; D Givol; E Canaani
Journal:  Nature       Date:  1982-12-16       Impact factor: 49.962

4.  Homology between an endogenous viral LTR and sequences inserted in an activated cellular oncogene.

Authors:  E L Kuff; A Feenstra; K Lueders; G Rechavi; D Givol; E Canaani
Journal:  Nature       Date:  1983-04-07       Impact factor: 49.962

5.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.

Authors:  A Ullrich; L Coussens; J S Hayflick; T J Dull; A Gray; A W Tam; J Lee; Y Yarden; T A Libermann; J Schlessinger
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

6.  Human DNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virus.

Authors:  R Watson; M Oskarsson; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

7.  A human c-erbA oncogene homologue is closely proximal to the chromosome 17 breakpoint in acute promyelocytic leukemia.

Authors:  A I Dayton; J R Selden; G Laws; D J Dorney; J Finan; P Tripputi; B S Emanuel; G Rovera; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.

Authors:  R Taub; I Kirsch; C Morton; G Lenoir; D Swan; S Tronick; S Aaronson; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Rearranged c-mos locus in a MOPC 21 murine myeloma cell line and its persistence in hybridomas.

Authors:  S Gattoni-Celli; W L Hsiao; I B Weinstein
Journal:  Nature       Date:  1983 Dec 22-1984 Jan 4       Impact factor: 49.962

10.  Isolation and characterization of multiple human genes homologous to the oncogenes of avian erythroblastosis virus.

Authors:  M Jansson; L Philipson; B Vennström
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  16 in total

1.  A rare c-mos RFLP in normal (noncancerous) fibroblasts from two related cancer patients.

Authors:  K D Dietrich; R M Fourney; R A Aubin; M C Paterson
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

Review 2.  Human chromosome 8.

Authors:  S Wood
Journal:  J Med Genet       Date:  1988-11       Impact factor: 6.318

Review 3.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

Review 4.  DNA polymorphism and the study of disease associations.

Authors:  D N Cooper; J F Clayton
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

5.  Presence of an EcoRI RFLP of the c-mos locus in normal and tumor tissue of esophageal cancer patients.

Authors:  M Hollstein; R Montesano; H Yamasaki
Journal:  Nucleic Acids Res       Date:  1986-11-11       Impact factor: 16.971

6.  Elevated frequency of an ETS-1 restriction fragment polymorphism in chronic B-cell leukaemia.

Authors:  P E Crossen; M J Morrison
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

Review 7.  Cellular oncogenes in neoplasia.

Authors:  V T Chan; J O McGee
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

8.  Epidermal growth factor receptors and prognosis in primary breast cancer.

Authors:  F Spyratos; J C Delarue; C Andrieu; R Lidereau; M H Champème; K Hacène; M Brunet
Journal:  Breast Cancer Res Treat       Date:  1990-12       Impact factor: 4.872

9.  Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.

Authors:  C Escot; C Theillet; R Lidereau; F Spyratos; M H Champeme; J Gest; R Callahan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

10.  Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.

Authors:  R Dolcetti; S Pelucchi; R Maestro; S Rizzo; A Pastore; M Boiocchi
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.